COVID‐19 vaccination in children and university students

John P. A. Ioannidis1,2
1Departments of Medicine, Epidemiology and Population Health, Biomedical Data Science, and Statistics, Stanford University, Stanford, CA, USA
2Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA

Tóm tắt

Abstract

Strategies for the use of COVID‐19 vaccines in children and young adults (in particular university students) are hotly debated and important to optimize. As of late August 2021, recommendations on the use of these vaccines in children vary across different countries. Recommendations are more uniform for vaccines in young adults, but vaccination uptake in this age group shows a large range across countries. Mandates for vaccination of university students are a particularly debated topic with many campuses endorsing mandates in the USA in contrast to European countries, at least as of August 2021. The commentary discusses the potential indirect impact of vaccination of youth on the COVID‐19 burden of disease for other age groups and societal functioning at large, estimates of direct impact on reducing fatalities and nonlethal COVID‐19‐related events in youth, estimates of potential lethal and nonlethal adverse events from vaccines and differential considerations that may exist in the USA, European countries and nonhigh‐income countries. Decision‐making for deploying COVID‐19 vaccines in young people is subject to residual uncertainty on the future course of the pandemic and potential evolution towards endemicity. Rational recommendations would also benefit from better understanding of the clinical and sociodemographic features of COVID‐19 risk in young populations and from dissecting the role of re‐infections and durability of natural vs. vaccine‐induced immunity.

Từ khóa


Tài liệu tham khảo

10.1542/peds.2021-052336

CDC director statement on Pfizer's use of COVID‐19 vaccine in adolescents age 12 and older.https://www.cdc.gov/media/releases/2021/s0512‐advisory‐committee‐signing.html. Accessed June 29 2021.

JCVI issues advice on COVID‐19 vaccination of children and young people.https://www.gov.uk/government/news/jcvi‐issues‐advice‐on‐covid‐19‐vaccination‐of‐children‐and‐young‐people. Accessed August 24 2021.

https://ourworldindata.org/grapher/covid‐fully‐vaccinated‐by‐age?country=~FRA. Accessed August 24 2021.

https://www.mayoclinic.org/coronavirus‐covid‐19/vaccine‐tracker. Accessed August 24 2021.

https://www.chronicle.com/blogs/live‐coronavirus‐updates/heres‐a‐list‐of‐colleges‐that‐will‐require‐students‐to‐be‐vaccinated‐against‐covid‐19. Accessed August 24 2021.

https://www.researchprofessionalnews.com/rr‐news‐europe‐universities‐2021‐8‐mixed‐picture‐on‐mandatory‐vaccines. Accessed August 24 2021.

10.1001/jamapediatrics.2020.3019

10.1136/bmj.n1197

10.1038/s41541-021-00362-z

Child mortality and COVID‐19.https://data.unicef.org/topic/child‐survival/covid‐19. Accessed August 24 2021.

10.1016/S0140-6736(17)33293-2

10.1111/eci.13554

Pezzullo AM, 2021, Change in age distribution of COVID‐19 deaths with the introduction of COVID‐19 vaccination, medRxiv

10.1056/NEJMoa2104882

10.1055/a-1499-0119

10.15585/mmwr.mm7027e2

Rosenblum HG, 2021, Use of COVID‐19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson & Johnson) and mRNA COVID‐19 Vaccines (Pfizer‐BioNTech and Moderna): update from the Advisory Committee on Immunization Practices ‐ United States, July 2021, MMWR Morb Mortal Wkly Rep, 70, 1094, 10.15585/mmwr.mm7032e4

10.1001/jama.2021.3976

10.1007/s10654-021-00787-9

10.1542/hpeds.2021-006001

10.1001/jamanetworkopen.2021.11417

10.1136/bmjebm-2021-111735

10.1136/bmj.n1244

10.1038/s41586-020-2521-4

10.1001/jamapediatrics.2021.1685

10.1016/j.puhe.2020.11.005

10.1542/peds.2020-009951

10.1111/eci.13520

10.1093/cid/ciab717

10.1038/d41586-021-02158-6

Gazit S, 2021, Comparing SARS‐CoV‐2 natural immunity to vaccine‐induced immunity: reinfections versus breakthrough infections, medRxiv

Serotracker.https://serotracker.com/en/Explore. Accessed August 31 2021.

10.1371/journal.pone.0252617

10.1111/eci.13222

10.1016/S0140-6736(21)00617-6

10.1136/bmj.n2019